Rezolute, Inc. (NASDAQ:RZLT) has received an average "Hold" rating from eleven analysts, with one sell, four hold, and six buy recommendations, and an average one-year price target of $8.00. The clinical-stage biopharma is developing RZ358 for congenital hyperinsulinism and RZ402 for diabetic macular edema. Despite recent positive analyst upgrades and significant institutional ownership, the company reported an EPS miss of ($0.22) and is projected to post a -0.93 EPS for the current fiscal year.

Cottage Street Advisors LLC significantly reduced its stake in ONEOK, Inc. (NYSE:OKE) by selling 36,511 shares, bringing its total holdings to 11,147 shares valued at $819,000. Meanwhile, other institutional investors like TCV Trust & Wealth Management Inc. and Empowered Funds LLC increased their positions in the utilities provider. ONEOK recently reported strong quarterly earnings, beating analyst estimates with $1.55 EPS and $9.07 billion in revenue, and subsequently raised its quarterly dividend to $1.07.

Consolidated Portfolio Review Corp recently acquired 276,530 shares of Roivant Sciences (NASDAQ:ROIV) in Q4, a stake valued at approximately $6.0 million, making it their 21st largest holding. Despite this institutional buying, insiders have been net sellers, disposing of over 4.5 million shares worth $124.85 million in the last three months. Roivant Sciences currently holds a "Moderate Buy" consensus from analysts with an average price target of $29.50.

Consolidated Portfolio Review Corp significantly increased its stake in Invesco QQQ (QQQ) by 1,182.5% in Q4, making it their fourth-largest holding. Other institutions have also boosted their positions, contributing to QQQ's significant institutional ownership. Despite positive institutional demand and daily ETF inflows, QQQ faces potential downside risks from Federal Reserve tightening, rising inflation, and ongoing geopolitical tensions.

This article analyzes the Q4 performance of Yum China (NYSE:YUMC) and other traditional fast-food stocks, highlighting top and bottom performers. Yum China delivered an exceptional quarter with strong revenue growth and exceeded analyst expectations, though its stock saw a slight dip. Krispy Kreme (NASDAQ:DNUT) was the best performer with an impressive stock increase, while Jack in the Box (NASDAQ:JACK) reported the weakest Q4 performance with a significant stock decline.

Raymond James has upgraded Equitable Holdings (NYSE: EQH) to Strong Buy with a $58 price target, citing a favorable outlook for its merger with Corebridge Financial. The upgrade is driven by the combined entity's distribution strength, in-house asset management, and potential for over $1 billion in synergies. Despite a recent 11% year-to-date stock decline, the firm sees an opportunity, noting management's share buybacks and consistent dividend increases.

Farther Finance Advisors LLC significantly increased its stake in RTX Corporation by acquiring an additional 11,734 shares, bringing its total ownership to 59,092 shares valued at $10.84 million. This move aligns with other institutional investors who have also adjusted their holdings in the aerospace and defense company, which recently reported strong earnings and announced a quarterly dividend. Analyst sentiment toward RTX is generally positive, with a "Moderate Buy" consensus rating and a price target of $203.61, despite some insider selling activity and concerns about its high valuation.

Rentokil Initial reported a mixed Q1 2026 performance with group revenue up 4.3% and solid organic growth in North America. Despite these positive figures and ongoing M&A activity, shares slid due to investor caution over geopolitical uncertainties mentioned by CEO Mike Duffy. The company remains confident in meeting full-year expectations despite these challenges.

Farther Finance Advisors LLC increased its stake in McDonald's Corporation by 37.2%, acquiring an additional 8,928 shares to bring its total holdings to 32,924 shares valued at $10.06 million. The article also details significant increases in McDonald's holdings by other institutional investors and discusses positive, neutral, and negative news impacting the company, including value menu expansion, commodity cost pressures, and recent insider stock sales.

Diversified Management Inc. has initiated a new position in Cisco Systems (NASDAQ:CSCO), purchasing 16,837 shares valued at approximately $1.30 million during the fourth quarter. This investment comes as Cisco beat Q4 earnings estimates with strong revenue growth driven by AI-networking demand, leading to raised guidance and a "Moderate Buy" consensus from analysts. However, the company faces investor concerns regarding the $28 billion Splunk deal's impact on debt and free cash flow, alongside a recent Zacks downgrade and insider selling, despite a quarterly dividend increase.